| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b08fd5336ec3dd22e427176de8f588a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39bf0bb8b07e151d4bcead749d7dd699 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104 |
| filingDate |
2013-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f197c8f1b25732c4f45bd81bc7102109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502e12da3f6a2a515927daedcce73cf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb469993696de41d6dc2c7815002abb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b45b470608503477035201221c2233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb990dde10d374588252455ccc4f957a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee5e32d87a579e80bcf8743767586ac8 |
| publicationDate |
2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111249455-A |
| titleOfInvention |
Pseudomonas antigens and antigen combinations |
| abstract |
An effective Pseudomonas aeruginosa vaccine may require one or several antigenic components, so a variety of Pseudomonas aeruginosa antigens have been identified for immunization. These polypeptides can optionally be used in combination with other nosocomial antigens. |
| priorityDate |
2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |